AzTrials
AzTrials

Cardiac Surgery PatientsNCT06402903

Physiotherapy in Patients in a Cardiac Intensive Care Unit

An observational study of Cardiac Surgery Patients, run by University of Oviedo at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background. Cardiovascular diseases are a major cause of morbidity and mortality. The management of these patients requires multidisciplinary therapeutic approaches. Physiotherapy plays a fundamental role in the postoperative management of patients undergoing cardiac surgery. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Cardiac Surgery Patients
What is being tested?
Observation
Type of treatment
Injection or infusion
How many people
110 participants
Where
1 siteSpain
Study dates
6 May 2024to 20 May 2024
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The data will be collected in May 2024 at the Physical Medicine and Rehabilitation Service of the Hospital Universitario Central de Asturias (HUCA), belonging to the Health Area IV of the Health Service of the Principality of Asturias.

Who may be able to join

  • Patients diagnosed with cardiac pathology
  • Undergoing cardiac surgery at the Hospital Universitario Central de Asturias between 1 January and 31 March 2023
  • In the postoperative phase in the Intensive Care Unit and subsequently on transfer to the ward, they received physiotherapy treatment or not.
  • That the period of stay in the ICU was less than 30 days.

Who cannot join

  • Patients with comorbidities prior to surgery that hindered independence from third parties in the performance of activities of daily living and ambulation; iii) patients with previous cardiac surgeries; and iv) patients whose study variables were not fully recorded in the Medical History.
  • Patients with previous cardiac surgeries
  • Patients whose study variables were not fully recorded in the Clinical History.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Oviedo

    Oviedo, Principality of Asturias, 33006

Other trials in Spain

About this study

Official title: Physiotherapy in Patients in a Cardiac Intensive Care Unit. A Retrospective Cohort Study

Background. Cardiovascular diseases are a major cause of morbidity and mortality. The management of these patients requires multidisciplinary therapeutic approaches. Physiotherapy plays a fundamental role in the postoperative management of patients undergoing cardiac surgery.

Objective: To analyse the relationship between the administration of a physiotherapy intervention and the time spent in the cardiac ICU and on the ward.

Read more

Method. Retrospective cohort study. The medical records of 110 patients undergoing cardiac surgery who received a Physiotherapy intervention during their stay in the Intensive Care Unit will be analysed. Data will be collected from patients admitted to the cardiac ICU in 2023. The variables assessed will be: length of stay in ICU and hospital admission (days), age (years completed), weight (kg) and sex. A one-factor analysis of variance will be performed to calculate the association between the variables and a linear regression analysis will be used to describe the hospital stay variables as a function of the other predictor variables.

Expected outcomes. Physiotherapy treatment in an Intensive Care Unit improves ICU and hospital stay times in patients undergoing cardiac surgery.

Being tested
Observation
Keywords
Physiotherapy, Intensive Care Unit, Postoperative complications prevention, Cardiac surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ObservationOther

    The clinical, post-surgical and anthropometric variables of the patients, as well as the time spent in the Intensive Care Unit and on the hospital ward (in days) were collected in the Clinical Histories.

    The collection of data from the Clinical Histories will be carried out by the principal investigator, an employee of the Hospital Universitario Central de Asturias, in accordance with current data protection regulations, scrupulously complying with the anonymous collection of clinical data, and without collecting any data that could allow the identification of the patients whose data were collected.

    The data from the Clinical Histories will be exported to an Excel file which will subsequently be anonymised. Access to the Excel file will require a password access that will be managed from a computer of the University of Oviedo (Department of Surgery and Medical-Surgical Specialties).

Study groups in NCT06402903
Study groupRoleWhat they receive
Observacional groupThe data will be collected in April 2024 at the Physical Medicine and Rehabilitation Service of the Central University Hospital of Asturias (HUCA), belonging to Health Area IV of the Health Service of the Principality of Asturias.
Receives: Other: Observation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess length of stay in the Intensive Care Unit

    This period shall be calculated (in days) by subtracting the date of admission to the Intensive Care Unit from the date of discharge from the Intensive Care Unit.

    Measured: Screening visit

  2. Assess time from hospital admission to medical discharge

    This period shall be calculated (in days) by subtracting the date of admission to the Intensive Care Unit from the date of discharge.

    Measured: Screening visit

Secondary outcomes (4)
  1. Assess the age

    This quantitative variable will indicate the age of the patients (in years of age) at the time of admission to the Intensive Care Unit.

    Measured: Screening visit

  2. Assess the gender

    This dichotomous variable (Female / Male) will indicate the sex of the patient at the time of admission to the Intensive Care Unit.

    Measured: Screening visit

  3. Assess the weight

    The weight at the time of the patient's admission to the hospital will be assessed (in kg)

    Measured: Screening visit

  4. Assess the administration of a physiotherapy intervention

    This dichotomous variable (Yes / No) will indicate whether the patient has received physiotherapy intervention during his/her stay in the Intensive Care Unit.

    Measured: Screening visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2024
  2. Study start6 May 2024
  3. Primary completion7 May 2024
  4. Study completion20 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
110 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06402903
Sponsor's protocol ID
FisCard
Status last verified
May 2024
First submitted
2 May 2024
Last updated
22 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Surgery Patients, run by University of Oviedo at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess length of stay in the Intensive Care Unit (time frame: Screening visit). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in